HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-13
DOI
10.3389/fimmu.2018.02605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
- (2017) Angela DeMichele et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stromal and intraepithelial tumor‑infiltrating lymphocytes in colorectal carcinoma
- (2017) Katarzyna Jakubowska et al. Oncology Letters
- Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
- (2017) Azharuddin Sajid Syed Khaja et al. Oncotarget
- Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
- (2016) Douglas B. Johnson et al. Nature Communications
- IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment
- (2015) Luciana Benevides et al. CANCER RESEARCH
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- The role of inflammation in progression of breast cancer: Friend or foe? (Review)
- (2015) MICHAEL D. ALLEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Identification and Clinical Relevance of Naturally Occurring Human CD8+HLA-DR+Regulatory T Cells
- (2014) Lourdes Arruvito et al. JOURNAL OF IMMUNOLOGY
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia
- (2014) LIMIN XING et al. Molecular Medicine Reports
- The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
- (2014) Yan Mao et al. PLoS One
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Neoadjuvant Therapy in the Treatment of Breast Cancer
- (2014) Mediget Teshome et al. Surgical Oncology Clinics of North America
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Secondary T cell–T cell synaptic interactions drive the differentiation of protective CD8+ T cells
- (2013) Audrey Gérard et al. NATURE IMMUNOLOGY
- Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
- (2013) T Xiang et al. ONCOGENE
- Neoadjuvant treatment of breast cancer
- (2012) A. M. Thompson et al. ANNALS OF ONCOLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Normalized Median Fluorescence: An Alternative Flow Cytometry Analysis Method for Tracking Human Embryonic Stem Cell States During Differentiation
- (2012) Lesley Y. Chan et al. TISSUE ENGINEERING PART C-METHODS
- Role of interleukin-10 in breast cancer
- (2011) Hamidullah et al. BREAST CANCER RESEARCH AND TREATMENT
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
- Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
- (2010) Takashi Inozume et al. JOURNAL OF IMMUNOTHERAPY
- Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
- (2008) Helena Hornychová et al. CANCER INVESTIGATION
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started